Beactica

Beactica is a drug discovery company that utilizes its proprietary methods to evaluate molecular interactions in order to generate new therapeutic approaches. We provide expertise and services in the field of small molecule interaction analysis based on SPR biosensors, as well as partnerships for fragment-based lead generation using our proprietary Sprint™ platform. Founded in 2006 based on research from Uppsala University and first-hand experience in the drug discovery industry, Beactica has become a leader in SPR biosensor-based small molecule drug discovery. In addition to offering services and establishing collaborations with external companies, Beactica is also advancing its own drug discovery programs.